Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.
about
Sulfasalazine for ankylosing spondylitisSpontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.Evaluation of treatments for sacroiliitis in spondyloarthropathy using the Spondyloarthritis Research Consortium Canada scoring system.Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.Treatment challenges in axial spondylarthritis and future directions.Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.Anti-TNFs in axial spondyloarthritis.Pharmacological therapy of spondyloarthritis.Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review.Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up.Recommendations for the management and treatment of ankylosing spondylitis.Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: a three years' following-up study.Long-term efficacy of adalimumab after drug withdrawal and retreatment in patients with active non-radiographically evident axial spondyloarthritis who experience a flare.Fast relapse upon discontinuation of tumour necrosis factor blocking therapy in patients with peripheral spondyloarthritis.The current standard of care and the unmet needs for axial spondyloarthritis
P2860
Q24187791-F02205A3-5F20-4B58-B863-04D21C6FF558Q34894874-0AD5A5C7-EE89-4D91-BCA6-9D3207491C4BQ36525929-A0EE8A88-A252-45EB-892B-ABF662C87811Q37215981-2D7E56FA-6DC3-47D8-9D20-7A68A66552A6Q37465472-5FF03DBD-ED25-4068-9F64-65692694AE9EQ38124281-3BDB41D4-29D2-40F3-94FD-625B46F6A2EDQ38198090-7DFD147E-7C14-43CE-BB39-1E05DE33CF39Q38311916-5F0C37E1-EAB8-4463-8C8D-62B3D9E525A6Q38527552-47A7AECE-DAB5-4BA7-896C-6BC67AA78E61Q38611064-0756F36C-419A-49D4-8247-674D4F6CF96DQ38711954-21F91BE0-5886-4633-9396-143199EC6203Q38783099-937F2DDE-B769-4F02-AA3E-F0A5B8D469F1Q38972623-449DC2A1-03C9-4C21-8B56-81CFBC115E22Q44581266-BB936716-7CD4-474E-B3E5-EF53613B35DEQ44898441-78F71B7F-ECD0-4792-8BB8-C76E21AACF14Q50508474-009AE4B2-91F7-402E-8E5B-C28044A8B71FQ50981635-1AB2D1D2-DC21-46B2-B906-56BE0A090591Q51005451-C7064B24-99D5-4D09-8993-72F0E70B0719Q59134860-CCE5473D-0F71-4C28-A563-13FA41EB4085
P2860
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Frequency and duration of drug ...... year data of the ESTHER trial.
@ast
Frequency and duration of drug ...... year data of the ESTHER trial.
@en
Frequency and duration of drug ...... year data of the ESTHER trial.
@nl
type
label
Frequency and duration of drug ...... year data of the ESTHER trial.
@ast
Frequency and duration of drug ...... year data of the ESTHER trial.
@en
Frequency and duration of drug ...... year data of the ESTHER trial.
@nl
prefLabel
Frequency and duration of drug ...... year data of the ESTHER trial.
@ast
Frequency and duration of drug ...... year data of the ESTHER trial.
@en
Frequency and duration of drug ...... year data of the ESTHER trial.
@nl
P2093
P50
P1476
Frequency and duration of drug ...... year data of the ESTHER trial.
@en
P2093
Bruce Freundlich
Christian E Althoff
Hildrun Haibel
In-Ho Song
Joachim Listing
Joachim Sieper
Martin Bohl-Bühler
Martin Rudwaleit
Svetlana Djacenko
P304
P356
10.1136/ANNRHEUMDIS-2011-201010
P407
P577
2012-03-22T00:00:00Z